California Life Sciences
Jeff Landau currently serves as Chief Business Officer and Head of Strategy at CytomX Therapeutics since April 2021 and holds board positions at California Life Sciences and Sunshine Bio. Landau has extensive experience in business development, corporate strategy, and investment within the life sciences sector, having previously worked at Catalyst Biosciences and Threshold Pharmaceuticals, among others. Educationally, Landau earned an MBA in Health Care Entrepreneurship and Leadership from Stanford University and a BS in Biotechnology/Biochemistry from Virginia Tech, graduating Cum Laude with honors.
This person is not in the org chart
California Life Sciences
California Life Sciences (CLS) is the state’s most influential and impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology.